Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review
Therapeutic Apheresis and Dialysis · 2026-08 · 30 (4) · 482-488
DOI: 10.1002/1744-9987.70155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 11.05.2026. Verfasst von Mahtab Mashayekhi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Erythrocytaphoresis or RBC exchange (RBCX) is a key intervention in the management of sickle cell anemia for both chronic prophylaxis and emergent clinical care during sickle cell disease (SCD) emergencies. RBCX removes sickled RBCs while replacing them with donor RBCs and reducing hemoglobin S (HbS) levels. Unlike simple transfusion, it minimizes iron overload and avoids fluid overload, making it a mainstay for the management of acute stroke, acute chest syndrome, and other settings where fluid overload can complicate disease morbidity. Chronic RBCX has shown benefit in not only improving oxygenation and reducing hospitalization rates but also improving overall quality of life in SCD patients. Advances in apheresis technology and personalized transfusion have brought new opportunities for enhancement in safety, efficacy, and feasibility of this therapeutic modality. In this review, we explore the clinical efficacy and role of chronic RBC exchange and its long‐term outcomes in managing complications of SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA.
- Department of Medicine, Division of Transplant, Cellular Therapy and Hematological Malignancies, Loma Linda University School of Medicine, Loma Linda, California, USA.
- Department of Pediatrics, Division of Hematology/Oncology, Loma Linda University School of Medicine, Loma Linda, California, USA.
- Department of Medicine, Capital Health Regional Medical Center, Trenton, New Jersey, USA.
ORCID-Profile: Nasim Salimiaghdam
Zitieren
APA
Mashayekhi, M., Akhtari, M., Jain, A., Salimiaghdam, N., & Abdipour, A. (2026). Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review. Therapeutic Apheresis and Dialysis, 30(4), 482-488. https://doi.org/10.1002/1744-9987.70155
Vancouver
Mashayekhi M, Akhtari M, Jain A, Salimiaghdam N, Abdipour A. Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review. Therapeutic Apheresis and Dialysis. 2026;30(4):482-488. doi:10.1002/1744-9987.70155
BibTeX
@article{Mashayekhi2026,
author = {Mashayekhi, Mahtab and Akhtari, Mojtaba and Jain, Akshat and Salimiaghdam, Nasim and Abdipour, Amir},
title = {Red Blood Cell Exchange in Sickle Cell Disease Care: A Comprehensive Review},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
volume = {30},
number = {4},
pages = {482--488},
doi = {10.1002/1744-9987.70155}
}
EUVIMED